KALA BIO, Inc. (0JQ2.L) LSE

0.66

+0.0475(+7.72%)

Updated at December 24 05:58PM

Currency In USD

Valuation

Market Cap38.31M
Enterprise Value19.38M
P/E Ratio-0.13
PEG Ratio-0.01
Price/Sales Ratio17.7
Price/Book Ratio-0.52
Enterprise/Revenue52.53
Enterprise/EBITDA-0.43

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterSeptember 30, 2025

Profitability

Profit Margin-141.11
Operating Margin-150.56

Management Effectiveness

Return On Assets-1.43
Return On Equity-23.24

Income Statement

Revenue0
Revenue/Share0.04
Gross Profit-259,000
EBITDA-40.98M
Net Income-38.51M
Diluted EPS-6.98

Balance Sheet

Total Cash21.1M
Total Cash/Share3
Total Debt29.94M
Total Debt/Equity-3.46
Current Ratio0.75
Book Value Per Share3.39

Price History

52-Week Change-90.62
52-Week High19.48
52-Week Low0.62
Moving Average 50 Days7.08
Moving Average 200 Days11.17

Statistics

Average Volume320
Shares Outstanding7.02M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split Factor1:50
Last Split DateJanuary 20, 2023